Hims And Hers Health Inc Revenue Growth Rates (HIMS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Hims and Hers Health Inc   (NYSE: HIMS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

HIMS's Revenue Growth by Quarter and Year

Hims And Hers Health Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/HIMS/growth
https://api.csimarket.com/api/v1/companies/HIMS/fundamentals
https://api.csimarket.com/api/v1/companies/HIMS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
HIMS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 890.37
2nd Quarter June 753.21
1st Quarter March 607.79
FY 2,251.37

HIMSs Annual Revenue
Hims And Hers Health Inc 's Revenue in the fiscal year 2025 $ 2,347.38 millions
Hims And Hers Health Inc 's Revenue in the fiscal year 2024 $ 1,476.14 millions
Hims And Hers Health Inc 's Revenue in the fiscal year 2023 $ 871.95 millions
Hims And Hers Health Inc 's Revenue in the fiscal year 2022 $ 526.92 millions
Hims And Hers Health Inc 's Revenue in the fiscal year 2021 $ 271.88 millions




HIMS Revenue third quarter 2026 Y/Y Growth Comment
Hims and Hers Health Inc reported Revenue rise of 48.88% year on year in the third quarter 2026, to $ 890.37 millions, this is lower than Hims And Hers Health Inc 's recent average Revenue rise of 70.37%.

Among companies who have reported third quarter 2026 results in the Healthcare Facilities industry only one Company has achieved higher year on year Revenue results in the third quarter 2026. While Hims And Hers Health Inc ' s Revenue jump of 48.88% ranks overall at the positon no. 594 in the third quarter 2026.


HIMS Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 48.88 %
2nd Quarter June 38.41 %
1st Quarter March 3.77 %
FY   -

Financial Statements
Hims And Hers Health Inc 's third quarter 2026 Revenue $ 890.37 millions HIMS's Income Statement
Hims And Hers Health Inc 's third quarter 2025 Revenue $ 598.06 millions Quarterly HIMS's Income Statement


HIMS Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 18.21 %
2nd Quarter June 23.93 %
1st Quarter March -1.88 %
FY (Year on Year)   -


Back to HIMS Growth rate Comparisons >> Back to HIMS Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #2
Healthcare Sector #141
Overall #594

Revenue Y/Y Growth Statistics
High Average Low
110.61 % 70.37 % 3.77 %
(Dec 31 2022)   (Jun 30 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #2
Healthcare Sector #141
Overall #594
Revenue Y/Y Growth Statistics
High Average Low
110.61 % 70.37 % 3.77 %
(Dec 31 2022)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Hims And Hers Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
27.54 % 13.88 % -7.08 %
(Sep 30 2022)  


HIMS's III. Quarter Q/Q Revenue Comment
Hims and Hers Health Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 18.21%, to $ 890.37 millions, from $753.21 millions in the second quarter.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Hims And Hers Health Inc 's Revenue growth quarter on quarter, overall rank is 464.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #96
Overall #464
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #96
Overall #464
Revenue Q/Q Growth Statistics
High Average Low
27.54 % 13.88 % -7.08 %
(Sep 30 2022)  


HIMS's III. Quarter Q/Q Revenue Comment
Hims and Hers Health Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 18.21%, to $ 890.37 millions, from $753.21 millions in the second quarter.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Hims And Hers Health Inc 's Revenue growth quarter on quarter, overall rank is 464.


Hims And Hers Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 2,578.49
Y / Y Revenue Growth (TTM) 28.14 %
Year on Year Revenue Growth Overall Ranking # 158
Seqeuential Revenue Change (TTM) 8.82 %
Seq. Revenue Growth (TTM) Overall Ranking # 1165


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Hims And Hers Health Inc 's cumulative twelve months Revenue were $ 2,578 millions, company would post below average annual Revenue growth of 8.82% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Hims And Hers Health Inc 's Revenue growth from the 753.21% growth in Mar 31 2026.

In the Healthcare sector 51 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 138 to 158.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 9
Healthcare Sector # 52
Overall # 158

Revenue TTM Y/Y Growth Statistics
High Average Low
93.81 %
 68.26 %
28.14 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 218
S&P 500 # 1165
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Hims And Hers Health Inc 's cumulative twelve months Revenue were $ 2,578 millions, company would post below average annual Revenue growth of 28.14% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Hims And Hers Health Inc 's Revenue growth from the 753.21% growth in Mar 31 2026.

In the Healthcare sector 51 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 138 to 158.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 9
Healthcare Sector # 52
Overall # 158

Revenue TTM Y/Y Growth Statistics
High Average Low
93.81 %
68.26 %
28.14 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 218
S&P 500 # 1165




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
HIMS's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions
Tg Therapeutics Inc 60.74%$ 60.743 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions
X4 Pharmaceuticals Inc58.64%$ 58.640 millions
Kiniksa Pharmaceuticals International Plc58.12%$ 58.121 millions
Envoy Medical Inc 57.14%$ 57.143 millions
Humacyte Inc 55.21%$ 55.208 millions
Butterfly Network Inc 53.45%$ 53.453 millions
Avita Medical Inc 53.05%$ 53.054 millions
Immunitybio inc 52.34%$ 52.338 millions
Axsome Therapeutics Inc 51.87%$ 51.873 millions
Innovative Eyewear Inc 51.12%$ 51.123 millions


About Hims And Hers Health Inc Revenue Growth Rates (HIMS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Hims and Hers Health Inc (CIK 1773751).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001773751-26-000246
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Hims and Hers Health Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.